Sign In
Buy R
$260.38
+2.32 (+0.90%)
At Close: Jun 03, 2026
Theralase(R) Bladder Cancer Clinical Data to be Presented at the 2026 American Urological Association Annual Meeting
07:00am, Tuesday, 10'th Feb 2026
Toronto, Ontario--(Newsfile Corp. - February 10, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated
Allianz Asset Management GmbH Boosts Stake in Ryder System, Inc. $R
05:24am, Tuesday, 10'th Feb 2026
Allianz Asset Management GmbH boosted its position in Ryder System, Inc. (NYSE: R) by 254.1% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Ex
Are Investors Undervaluing Ryder System (R) Right Now?
10:40am, Monday, 09'th Feb 2026
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Ryder System, Inc. (R) Hits Fresh High: Is There Still Room to Run?
10:17am, Monday, 09'th Feb 2026
Ryder (R) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Ryder Declares Quarterly Cash Dividend
04:30pm, Friday, 06'th Feb 2026
MIAMI--(BUSINESS WIRE)-- #RyderEverbetter--Ryder declares quarterly cash dividend, marking more than 49 years of uninterrupted dividend payments.
Ryder CEO to Address Barclays 43rd Annual Industrial Select Conference
06:55am, Thursday, 05'th Feb 2026
MIAMI--(BUSINESS WIRE)--Ryder System, Inc. (NYSE: R) Chairman & CEO Robert Sanchez to address the Barclays 43rd Annual Industrial Select Conference. Who: Ryder System, Inc. Chairman & CEO Robert Sa
Ryder (R) Earnings Expected to Grow: Should You Buy?
11:02am, Wednesday, 04'th Feb 2026
Ryder (R) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Theralase(R) Provides Update on Bladder Cancer Clinical Study
07:00am, Wednesday, 04'th Feb 2026
Interim clinical data has exceeded the recommended guidelines of the International Bladder Cancer Group for complete response and duration of complete response Toronto, Ontario--(Newsfile Corp. - Febr
Ryder CEO to Address Citi's 2026 Global Industrial Tech and Mobility Conference
06:55am, Wednesday, 04'th Feb 2026
MIAMI--(BUSINESS WIRE)--Ryder System, Inc. (NYSE: R) Chairman & CEO Robert Sanchez to address the 2026 Citi Global Industrial Tech and Mobility Conference. Who: Ryder System, Inc. Chairman & CEO Ro
JACKSON WY / ACCESS Newswire / February 3, 2026 / Kultura Brands Inc. (OTCID:LTNC) today announced that elite professional boxer Brandon Figueroa will compete in a featherweight world title fight this
Kirkman(R) Unveils Revolutionary L Reuteri: a Brain-Protective Probiotic with Immune Benefits
08:00am, Monday, 02'nd Feb 2026
Lake Oswego, Oregon--(Newsfile Corp. - February 2, 2026) - Functional Brands Inc. (NASDAQ: MEHA), parent company of Kirkman®, a trusted leader in high-quality dietary supplements, today announced the
AE Wealth Management LLC Has $26.58 Million Holdings in Ryder System, Inc. $R
03:05am, Friday, 30'th Jan 2026
AE Wealth Management LLC raised its stake in Ryder System, Inc. (NYSE: R) by 13.4% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commissio
New sublingual delivery system designed to enhance bioavailability and avoid gastric side effects many patients experience with clopidogrel. Clopidogrel, currently sold under the brand name Plavix®,
Zomedica Expands its TRUVIEW(R) Microscopy Platform with AI Diagnostic Interpretation, Growing its Market Opportunity
04:01pm, Friday, 23'rd Jan 2026
AI-enabled hematology and cytology analysis improves diagnostic speed, consistency, and workflow efficiency for veterinary clinics ANN ARBOR, MI / ACCESS Newswire / January 23, 2026 / Zomedica Corp. (
DWS CROCI (R) International Fund Buys 62,266 Shares of Societe Generale SA (XPAR:GLE)
09:10pm, Wednesday, 21'st Jan 2026
Summary DWS CROCI (R) International Fund raised its stake in Societe Generale SA (XPAR: GLE) by 213.17%, purchasing 62,266 shares to own 91,475 shares v
